{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:15:27Z","timestamp":1789992927343,"version":"4.0.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:00:00Z","timestamp":1583366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The way to a successful vaccine against human cytomegalovirus is hampered by the peculiar biology of this infection. However, some candidate vaccines have been shown to protect seronegative women and transplant recipients, and we should know soon whether they can prevent congenital infection.<\/jats:p>","DOI":"10.1093\/infdis\/jiz448","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T15:25:25Z","timestamp":1567178725000},"page":"S123-S127","source":"Crossref","is-referenced-by-count":28,"title":["Preventing Infection by Human Cytomegalovirus"],"prefix":"10.1093","volume":"221","author":[{"given":"Stanley A","family":"Plotkin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Pennsylvania, Vaxconsult, Doylestown, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"2020030507500367800_CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(74)92997-3","article-title":"Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero","volume":"1","author":"Elek","year":"1974","journal-title":"Lancet"},{"key":"2020030507500367800_CIT0002","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/IAI.12.3.521-527.1975","article-title":"Candidate cytomegalovirus strain for human vaccination","volume":"12","author":"Plotkin","year":"1975","journal-title":"Infect Immun"},{"key":"2020030507500367800_CIT0003","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(84)90930-9","article-title":"Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants","volume":"1","author":"Plotkin","year":"1984","journal-title":"Lancet"},{"key":"2020030507500367800_CIT0004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0264-410X(90)90135-9","article-title":"Isolated gA\/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers","volume":"8","author":"Gonczol","year":"1990","journal-title":"Vaccine"},{"key":"2020030507500367800_CIT0005","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1086\/315022","article-title":"A subunit cytomegalovirus vaccine based on recombinant envelope glycoprotein B and a new adjuvant","volume":"180","author":"Pass","year":"1999","journal-title":"J Infect Dis"},{"key":"2020030507500367800_CIT0006","article-title":"The National Academies Collection: reports funded by National Institutes of Health","volume-title":"Vaccines for the 21st century: a tool for decisionmaking","author":"Institute of Medicine Committee to Study Priorities for Vaccine Development","year":"2000"},{"key":"2020030507500367800_CIT0007","doi-asserted-by":"crossref","first-page":"B197","DOI":"10.1016\/j.vaccine.2012.10.074","article-title":"Desirability and feasibility of a vaccine against cytomegalovirus","volume":"31","author":"Griffiths","year":"2013","journal-title":"Vaccine"},{"key":"2020030507500367800_CIT0008","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00300-16","article-title":"Additive protection against congenital cytomegalovirus conferred by combined glycoprotein B\/pp65 vaccination using a lymphocytic choriomeningitis virus vector","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin Vaccine Immunol"},{"key":"2020030507500367800_CIT0009","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00030-18","article-title":"Advancing our understanding of protective maternal immunity as a guide for development of vaccines to reduce congenital cytomegalovirus infections","volume":"92","author":"Permar","year":"2018","journal-title":"J Virol"},{"key":"2020030507500367800_CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.089","article-title":"Vaccination against the human cytomegalovirus","author":"Plotkin","year":"2018","journal-title":"Vaccine"},{"key":"2020030507500367800_CIT0011","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJMoa0804749","article-title":"Vaccine prevention of maternal cytomegalovirus infection","volume":"360","author":"Pass","year":"2009","journal-title":"N Engl J Med"},{"key":"2020030507500367800_CIT0012","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/infdis\/jir138","article-title":"Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women","volume":"203","author":"Sabbaj","year":"2011","journal-title":"J Infect Dis"},{"key":"2020030507500367800_CIT0013","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.vaccine.2015.11.056","article-title":"Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: a randomized clinical trial","volume":"34","author":"Bernstein","year":"2016","journal-title":"Vaccine"},{"key":"2020030507500367800_CIT0014","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0140-6736(11)60136-0","article-title":"Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial","volume":"377","author":"Griffiths","year":"2011","journal-title":"Lancet"},{"key":"2020030507500367800_CIT0015","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1016\/j.vaccine.2018.07.056","article-title":"Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response","author":"Cui","year":"2018","journal-title":"Vaccine"},{"key":"2020030507500367800_CIT0016","doi-asserted-by":"crossref","first-page":"18153","DOI":"10.1073\/pnas.0509201102","article-title":"Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism","volume":"102","author":"Wang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507500367800_CIT0017","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.1921","article-title":"Maternal immune correlates of protection from human cytomegalovirus transmission to the fetus after primary infection in pregnancy","volume":"27","author":"Lilleri","year":"2017","journal-title":"Rev Med Virol"},{"key":"2020030507500367800_CIT0018","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/319680","article-title":"A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects","volume":"183","author":"Berencsi","year":"2001","journal-title":"J Infect Dis"},{"key":"2020030507500367800_CIT0019","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1073\/pnas.1800177115","article-title":"HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions","volume":"115","author":"Nelson","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507500367800_CIT0020","doi-asserted-by":"publisher","DOI":"10.3390\/v10120704","article-title":"Pathogen at the gates: human cytomegalovirus entry and cell tropism","volume":"10","author":"Nguyen","year":"2018","journal-title":"Viruses"},{"key":"2020030507500367800_CIT0021","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cid\/cix337","article-title":"Risk factors for congenital cytomegalovirus infection following primary and nonprimary maternal infection: a prospective neonatal screening study using polymerase chain reaction in saliva","volume":"65","author":"Leruez-Ville","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2020030507500367800_CIT0022","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000477168","article-title":"Perinatal outcomes of non-primary maternal cytomegalovirus infection: a 15-year experience","volume":"43","author":"Simonazzi","year":"2018","journal-title":"Fetal Diagn Ther"},{"key":"2020030507500367800_CIT0023","doi-asserted-by":"publisher","DOI":"10.3390\/v10070383","article-title":"There is always another way! cytomegalovirus' multifaceted dissemination schemes","volume":"10","author":"Jackson","year":"2018","journal-title":"Viruses"},{"key":"2020030507500367800_CIT0024","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/600882","article-title":"Birth prevalence and natural history of congenital cytomegalovirus infection in a highly seroimmune population","volume":"49","author":"Mussi-Pinhata","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020030507500367800_CIT0025","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1073\/pnas.1814835116","article-title":"HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission","volume":"116","author":"Vanarsdall","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2020030507500367800_CIT0026","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126047","article-title":"Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques","volume":"4","author":"Petitdemange","year":"2019","journal-title":"JCI Insight"},{"key":"2020030507500367800_CIT0027","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/INF.0000000000001877","article-title":"Nonprimary maternal cytomegalovirus infection after viral shedding in infants","volume":"37","author":"Boucoiran","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2020030507500367800_CIT0028","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02392-16","article-title":"Congenital human cytomegalovirus infection and the enigma of maternal immunity","volume":"91","author":"Britt","year":"2017","journal-title":"J Virol"},{"key":"2020030507500367800_CIT0029","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12594","article-title":"Cytomegalovirus infection in solid organ transplant recipients","volume":"20","author":"Lumbreras","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2020030507500367800_CIT0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.blre.2017.01.002","article-title":"The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: why the quest for meaningful prophylaxis still matters","volume":"31","author":"Chan","year":"2017","journal-title":"Blood Rev"},{"key":"2020030507500367800_CIT0031","article-title":"The status of vaccine development against the human cytomegalovirus","author":"Plotkin","year":"2019","journal-title":"J Infect Dis"},{"key":"2020030507500367800_CIT0032","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.vaccine.2013.09.042","article-title":"Priorities for CMV vaccine development","volume":"32","author":"Krause","year":"2013","journal-title":"Vaccine"},{"key":"2020030507500367800_CIT0033","article-title":"Mathematical models of vaccination for preventing congenital cytomegalovirus infection","author":"Lanzieri","year":"2019","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/221\/Supplement_1\/S123\/32791371\/jiz448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/221\/Supplement_1\/S123\/32791371\/jiz448.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T07:50:21Z","timestamp":1583394621000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/221\/Supplement_1\/S123\/5781908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":33,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2020,3,5]]},"published-print":{"date-parts":[[2020,3,5]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz448","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3,15]]},"published":{"date-parts":[[2020,3,5]]}}}